According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, the novel monoclonal antibody linavonkibart demonstrated the…
Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with systemic lupus erythematosus (SLE). In the phase 3 TULIP-SC trial, anifrolumab met its primary BICLA endpoint…
Getting a full night of sleep may play a larger role in longevity than many people realize. New research from Oregon Health & Science University indicates that regularly getting too…
USA: A new study, published in Ophthalmology, has revealed that the Pooled Cohort Equations cardiovascular risk score—which integrates age, sex, blood pressure, cholesterol levels, and smoking status to estimate 10-year…
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment for adults whose depression has not responded adequately to antidepressants. Developed by Neurolief, the…
China: A large real-world study from Hong Kong suggests that rosuvastatin and atorvastatin have comparable effects on progression to end-stage kidney disease (ESKD) in Chinese patients with diabetes. While rosuvastatin…
USA: Researchers have reported that low vitamin D levels are strongly linked to a higher risk of death and cardiovascular complications in patients with systemic lupus erythematosus (SLE), highlighting a…
Child and neonatal health remains a significant global and national priority, serving as a crucial indicator of a nation's well-being and developmental progress. Annually, millions of infants worldwide are affected…
The FDA delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists flagged safety and efficacy concerns
Here are the top health stories for the day:NEET PG 2025 Cut-Off Fixed at -40: Doctors Warn of Merit DilutionDoctors have expressed their concerns over the recent decision of the…